In breast cancer models, loss of TRAIL expression activates the death receptor DR5, triggering NF-κB/p38-dependent adhesion phenotype switching in ECs to promote myeloid cell infiltration and tumor colonization 15. Here, TNFSF10 is linked to neoplasm.